Optimizing Combination Chemotherapy by Controlling Drug Ratios
Figure 1.
A common cytotoxicity analysis in cancer pharmacology: The dose-response curve. Shown here is the antitumor activity of paclitaxel administered to A2780 human ovarian cancer cells for 72h in vitro.